» Articles » PMID: 32341488

Plasma Linoleic Acid Levels and Cardiovascular Risk Factors: Results from the Norwegian ACE 1950 Study

Abstract

Background: A high intake of linoleic acid (LA), the major dietary polyunsaturated fatty acid (PUFA), has previously been associated with reduced cardiovascular (CV) morbidity and mortality in observational studies. However, recent secondary analyses from clinical trials of LA-rich diet suggest harmful effects of LA on CV health.

Methods: A total of 3706 participants, all born in 1950, were included in this cross-sectional study. We investigated associations between plasma phospholipid levels of LA and CV risk factors in a Norwegian general population, characterized by a relative low LA and high marine n-3 PUFA intake. The main statistical approach was multivariable linear regression.

Results: Plasma phospholipid LA levels ranged from 11.4 to 32.0 wt%, with a median level of 20.8 wt% (interquartile range 16.8-24.8 wt%). High plasma LA levels were associated with lower serum low-density lipoprotein cholesterol levels (standardized regression coefficient [Std. β-coeff.] -0.04, p = 0.02), serum triglycerides (Std. β-coeff. -0.10, p < 0.001), fasting plasma glucose (Std. β-coeff. -0.10, p < 0.001), body mass index (Std. β-coeff. -0.13, p < 0.001), systolic and diastolic blood pressure (Std. β-coeff. -0.04, p = 0.03 and Std. β-coeff. -0.02, p = 0.02, respectively) and estimated glomerular filtration rate (Std. β-coeff. -0.09, p < 0.001). We found no association between plasma LA levels and high-density lipoprotein cholesterol levels, glycated hemoglobin, carotid intima-media thickness, or C-reactive protein.

Conclusion: High plasma LA levels were favorably associated with several CV risk factors in this study of a Norwegian general population.

Citing Articles

Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases.

Dabravolski S, Bezsonov E, Baig M, Popkova T, Orekhov A Int J Mol Sci. 2021; 22(13).

PMID: 34203309 PMC: 8268967. DOI: 10.3390/ijms22136949.


Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19.

Kothapalli K, Park H, Brenna J Prostaglandins Leukot Essent Fatty Acids. 2020; 162:102183.

PMID: 33038834 PMC: 7527828. DOI: 10.1016/j.plefa.2020.102183.

References
1.
Whelan J, Fritsche K . Linoleic acid. Adv Nutr. 2013; 4(3):311-2. PMC: 3650500. DOI: 10.3945/an.113.003772. View

2.
Farvid M, Ding M, Pan A, Sun Q, Chiuve S, Steffen L . Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014; 130(18):1568-78. PMC: 4334131. DOI: 10.1161/CIRCULATIONAHA.114.010236. View

3.
Wu J, Lemaitre R, King I, Song X, Psaty B, Siscovick D . Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation. 2014; 130(15):1245-53. PMC: 4189990. DOI: 10.1161/CIRCULATIONAHA.114.011590. View

4.
Marklund M, Wu J, Imamura F, Del Gobbo L, Fretts A, de Goede J . Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019; 139(21):2422-2436. PMC: 6582360. DOI: 10.1161/CIRCULATIONAHA.118.038908. View

5.
Ramsden C, Zamora D, Leelarthaepin B, Majchrzak-Hong S, Faurot K, Suchindran C . Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013; 346:e8707. PMC: 4688426. DOI: 10.1136/bmj.e8707. View